Beta 521
Alternative Names: β-521Latest Information Update: 07 Jun 2022
At a glance
- Originator Benevira
- Class Antivirals
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical COVID 2019 infections
Most Recent Events
- 24 May 2022 Benevira in-licenses technology from Technion - Israel Institute of Technology for the development of beta 521
- 24 May 2022 Preclinical trials in COVID-2019 infections (Prevention) in USA (unspecified route) before May 2022
- 24 May 2022 Preclinical trials in COVID-2019 infections in USA (unspecified route)